Total Payments
$1,637
2024 Payments
$129.23
Companies
33
Transactions
70
Medicare Patients
703
Medicare Billing
$60,273
Payment Breakdown by Category
Food & Beverage$1,268 (77.5%)
Education$368.82 (22.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,268 | 65 | 77.5% |
| Education | $368.82 | 5 | 22.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $201.41 | 4 | $0 (2022) |
| Lilly USA, LLC | $151.08 | 5 | $0 (2019) |
| Amarin Pharma Inc. | $127.27 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $126.57 | 6 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $123.23 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $79.35 | 2 | $0 (2020) |
| Amgen Inc. | $78.25 | 5 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $73.07 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $68.37 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $66.70 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $129.23 | 6 | Novartis Pharmaceuticals Corporation ($55.20) |
| 2023 | $49.56 | 2 | Stemline Therapeutics Inc. ($25.02) |
| 2022 | $79.99 | 1 | Incyte Corporation ($79.99) |
| 2021 | $34.59 | 2 | Merck Sharp & Dohme Corporation ($18.20) |
| 2020 | $263.98 | 17 | Daiichi Sankyo Inc. ($34.76) |
| 2019 | $955.98 | 41 | Lilly USA, LLC ($151.08) |
| 2018 | $123.23 | 1 | Ipsen Biopharmaceuticals, Inc ($123.23) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Oncology | ||||||
| 05/03/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $18.91 | General |
| 04/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Oncology | ||||||
| 01/24/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Education | In-kind items and services | $23.50 | General |
| Category: Monoclonal Antibody | ||||||
| 10/25/2023 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: Oncology | ||||||
| 09/27/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Oncology | ||||||
| 04/19/2022 | Incyte Corporation | — | Education | Cash or cash equivalent | $79.99 | General |
| 10/01/2021 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.39 | General |
| 07/29/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Oncology | ||||||
| 03/11/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.12 | General |
| Category: Oncology | ||||||
| 03/09/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Oncology | ||||||
| 03/04/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $19.25 | General |
| Category: Oncology | ||||||
| 03/04/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Oncology | ||||||
| 02/24/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2020 | Celgene Corporation | INREBIC (Drug), Idhifa | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| Category: Hematology | ||||||
| 02/13/2020 | Jazz Pharmaceuticals Inc. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/03/2020 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2020 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Immunology | ||||||
| 01/29/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Oncology | ||||||
| 01/29/2020 | Agios Pharmaceuticals, Inc. | TIBSOVO (Drug), IDHIFA | Food and Beverage | Cash or cash equivalent | $14.34 | General |
| Category: Oncology | ||||||
| 01/21/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VONVENDI (Biological) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: HEMATOLOGY | ||||||
| 01/21/2020 | Secura Bio, Inc. | Farydak (Drug) | Food and Beverage | Cash or cash equivalent | $9.80 | General |
| Category: Oral Oncologic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 479 | 1,056 | $99,812 | $43,061 |
| 2022 | 8 | 224 | 366 | $35,198 | $17,211 |
Total Patients
703
Total Services
1,422
Medicare Billing
$60,273
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 222 | $37,911 | $18,863 | 49.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 62 | $14,964 | $7,960 | 53.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 49 | $6,566 | $2,912 | 44.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $6,327 | $2,346 | 37.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $5,791 | $2,288 | 39.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 98 | 252 | $3,303 | $2,117 | 64.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 67 | 190 | $10,070 | $1,967 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 31 | $3,786 | $1,764 | 46.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 67 | 194 | $7,566 | $1,476 | 19.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $3,528 | $1,369 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 73 | $11,899 | $6,885 | 57.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 26 | $5,928 | $3,468 | 58.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $4,980 | $2,471 | 49.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $4,069 | $2,127 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $1,482 | $866.32 | 58.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 33 | 60 | $3,180 | $621.00 | 19.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 33 | 64 | $2,496 | $487.04 | 19.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 45 | 97 | $1,164 | $285.18 | 24.5% |
About Dr. Annum Faisal, MD
Dr. Annum Faisal, MD is a Internal Medicine healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2016. The National Provider Identifier (NPI) number assigned to this provider is 1871945204.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Annum Faisal, MD has received a total of $1,637 in payments from pharmaceutical and medical device companies, with $129.23 received in 2024. These payments were reported across 70 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($1,268).
As a Medicare-enrolled provider, Faisal has provided services to 703 Medicare beneficiaries, totaling 1,422 services with total Medicare billing of $60,273. Data is available for 2 years (2022–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology, Internal Medicine
- Location Springfield, MO
- Active Since 07/11/2016
- Last Updated 07/22/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871945204
Products in Payments
- Vascepa (Drug) $127.27
- Onivyde (Drug) $123.23
- OPDIVO (Biological) $66.70
- KISQALI (Drug) $55.20
- VYXEOS (Drug) $51.00
- ULTOMIRIS (Drug) $43.53
- ZEJULA (Drug) $39.77
- GILOTRIF (Drug) $35.94
- Enhertu (Drug) $34.76
- TIBSOVO (Drug) $34.50
- Kyprolis (Biological) $34.01
- PROMACTA (Drug) $33.22
- Lenvima (Drug) $31.22
- VONVENDI (Biological) $30.88
- XALKORI (Drug) $29.91
- IMFINZI (Drug) $29.61
- ALIMTA (Drug) $26.67
- VORAXAZE (Drug) $25.46
- Orserdu (Drug) $25.02
- PLUVICTO (Drug) $24.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Springfield
Dr. Steven Gradney, M.d, M.D
Internal Medicine — Payments: $568,658
Internal Medicine $568,658
Dr. James Bonucchi, Do, DO
Internal Medicine — Payments: $304,681
Internal Medicine $304,681
John Flack, Md, Mph, MD, MPH
Internal Medicine — Payments: $125,897
Internal Medicine $125,897
Dr. Sudeshna Banerjee, Md, MD
Internal Medicine — Payments: $62,767
Internal Medicine $62,767
Dr. Paul Madaj, M.d, M.D
Internal Medicine — Payments: $58,030
Internal Medicine $58,030
Dr. Indrajeet Mahata, M.d, M.D
Internal Medicine — Payments: $47,372
Internal Medicine $47,372